Published in In Vivo on April 22, 2013
Differentiation arrest by hypoxia. J Biol Chem (2006) 1.71
Defining the priority of using 18F-FDG PET for recurrent cervical cancer. J Nucl Med (2004) 1.58
Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells. Toxicol Lett (2008) 1.56
Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? Eur J Nucl Med Mol Imaging (2004) 1.51
Gene expression profiles of normal human fibroblasts after exposure to ionizing radiation: a comparative study of low and high doses. Radiat Res (2005) 1.48
Enhanced cellular radiosensitivity induced by cofilin-1 over-expression is associated with reduced DNA repair capacity. Int J Radiat Biol (2013) 1.42
Discrimination of breast cancer by measuring prostate-specific antigen levels in women's serum. Anal Chem (2011) 1.42
Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy. Radiat Oncol (2011) 1.14
18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. J Nucl Med (2004) 1.11
Element composition of tea leaves and tea infusions and its impact on health. Bull Environ Contam Toxicol (2008) 1.05
Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model. Nucl Med Biol (2009) 1.04
Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer. J Clin Oncol (2003) 1.00
Radiation-induced senescence in securin-deficient cancer cells promotes cell invasion involving the IL-6/STAT3 and PDGF-BB/PDGFR pathways. Sci Rep (2013) 0.99
Prevalence, detection and treatment of delirium in terminal cancer inpatients: a prospective survey. Jpn J Clin Oncol (2008) 0.98
Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation. Radiology (2010) 0.98
The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. J Nucl Med (2005) 0.97
MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation. Radiother Oncol (2008) 0.97
Autophagy inhibition enhances apoptosis triggered by BO-1051, an N-mustard derivative, and involves the ATM signaling pathway. Biochem Pharmacol (2010) 0.94
Regulated expression of cofilin and the consequent regulation of p27(kip1) are essential for G(1) phase progression. Cell Cycle (2009) 0.94
Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells. Chem Biol Interact (2009) 0.93
Therapeutic efficacy evaluation of 111In-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imaging. J Nucl Med (2009) 0.93
The Cdk and PCNA domains on p21Cip1 both function to inhibit G1/S progression during hyperoxia. Am J Physiol Lung Cell Mol Physiol (2003) 0.93
Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients. J Nucl Med (2003) 0.93
Evaluation of pharmacokinetics of 111In-labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model. Cancer Biother Radiopharm (2009) 0.92
Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-κB expression in vitro and in vivo. Biomed Pharmacother (2011) 0.92
Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer. J Nucl Med (2006) 0.90
Construction of mutant TKGFP for real-time imaging of temporal dynamics of HIF-1 signal transduction activity mediated by hypoxia and reoxygenation in tumors in living mice. J Nucl Med (2009) 0.90
Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal. Biomed Pharmacother (2011) 0.90
Diagnostic and therapeutic evaluation of 111In-vinorelbine-liposomes in a human colorectal carcinoma HT-29/luc-bearing animal model. Nucl Med Biol (2008) 0.89
Targeting protective autophagy exacerbates UV-triggered apoptotic cell death. Int J Mol Sci (2012) 0.88
Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response. Radiat Oncol (2011) 0.88
Curcumin-induced apoptosis in human hepatocellular carcinoma j5 cells: critical role of ca(+2)-dependent pathway. Evid Based Complement Alternat Med (2012) 0.87
p53 modulates radiation sensitivity independent of p21 transcriptional activation. Am J Clin Oncol (2005) 0.86
Utilization of nuclear medicine scintigraphy in Taiwan, 1997-2009. Ann Nucl Med (2011) 0.86
A DNA vaccine against cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) prevents tumor growth. Biochem Biophys Res Commun (2013) 0.86
Evaluating the potential of 188Re-SOCTA-trastuzumab as a new radioimmunoagent for breast cancer treatment. Nucl Med Biol (2009) 0.86
Phase I/II clinical study of pulsed paclitaxel radiosensitization for thoracic malignancy: a therapeutic approach on the basis of preclinical research of human cancer cell lines. Clin Cancer Res (2003) 0.86
Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption. J Nucl Med (2005) 0.86
Serial in vivo imaging of the lung metastases model and gene therapy using HSV1-tk and ganciclovir. J Nucl Med (2006) 0.86
18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2006) 0.86
Development of pH sensitive 2-(diisopropylamino)ethyl methacrylate based nanoparticles for photodynamic therapy. Nanotechnology (2010) 0.86
Comparative benefits and limitations of 18F-FDG PET and CT-MRI in documented or suspected recurrent cervical cancer. Eur J Nucl Med Mol Imaging (2006) 0.85
Association of platelet-derived growth factor receptor β accumulation with increased oxidative stress and cellular injury in sestrin 2 silenced human glioblastoma cells. FEBS Lett (2011) 0.85
Using NF-κB as a molecular target for theranostics in radiation oncology research. Expert Rev Mol Diagn (2012) 0.85
XPC silencing sensitizes glioma cells to arsenic trioxide via increased oxidative damage. Toxicol Sci (2010) 0.85
Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model. J Nucl Med (2004) 0.84
Localized surface plasmon coupled fluorescence fiber-optic biosensor for alpha-fetoprotein detection in human serum. Biosens Bioelectron (2008) 0.84
Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer. Oncol Rep (2011) 0.84
Enhancement of p53-mutant human colorectal cancer cells radiosensitivity by flavonoid fisetin. Int J Radiat Oncol Biol Phys (2010) 0.84
Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. J Nucl Med (2004) 0.84
Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir. Eur J Nucl Med Mol Imaging (2003) 0.84
Validation of 4-[18F]-ADAM as a SERT imaging agent using micro-PET and autoradiography. Neuroimage (2009) 0.84
Combined effect of topical arsenic trioxide and radiation therapy on skin-infiltrating lesions of breast cancer-a pilot study. Anticancer Drugs (2003) 0.84
Receptor-binding, biodistribution, dosimetry, and micro-SPECT/CT imaging of 111In-[DTPA(1), Lys(3), Tyr(4)]-bombesin analog in human prostate tumor-bearing mice. Cancer Biother Radiopharm (2009) 0.83
Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population. World J Gastroenterol (2009) 0.83
Sorafenib inhibits TPA-induced MMP-9 and VEGF expression via suppression of ERK/NF-κB pathway in hepatocellular carcinoma cells. In Vivo (2012) 0.83
Cancer risk from medical radiation procedures for coronary artery disease: a nationwide population-based cohort study. Asian Pac J Cancer Prev (2013) 0.83
Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model. Anticancer Res (2012) 0.83
Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model. Anticancer Res (2009) 0.82
TIMP2 deficient mice develop accelerated osteoarthritis via promotion of angiogenesis upon destabilization of the medial meniscus. Biochem Biophys Res Commun (2012) 0.82
Depletion of securin induces senescence after irradiation and enhances radiosensitivity in human cancer cells regardless of functional p53 expression. Int J Radiat Oncol Biol Phys (2010) 0.82
Mirtazapine inhibits tumor growth via immune response and serotonergic system. PLoS One (2012) 0.82
A correlational study of suicidal ideation with psychological distress, depression, and demoralization in patients with cancer. Support Care Cancer (2014) 0.81
Biodistribution study of [(123)I] ADAM in mice: correlation with whole body autoradiography. Nucl Med Biol (2002) 0.81
Evaluation of dose distribution of molecular delivery after blood-brain barrier disruption by focused ultrasound with treatment planning. Ultrasound Med Biol (2013) 0.81
Therapeutic efficacy evaluation of curcumin on human oral squamous cell carcinoma xenograft using multimodalities of molecular imaging. Am J Chin Med (2010) 0.81
Kinetics of glucose mutarotation assessed by an equal-amplitude paired polarized heterodyne polarimeter. J Phys Chem A (2010) 0.81
Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA). Anticancer Res (2009) 0.81
Involvement of a p53-independent and post-transcriptional up-regulation for p21WAF/CIP1 following destabilization of the actin cytoskeleton. Int J Oncol (2009) 0.80
Change of plasma transforming growth factor-beta1 levels in nasopharyngeal carcinoma patients treated with concurrent chemo-radiotherapy. Jpn J Clin Oncol (2005) 0.80
Demoralization syndrome among cancer outpatients in Taiwan. Support Care Cancer (2011) 0.80
Synthesis and evaluation of [18F]Fluorobutyl ethacrynic amide: a potential PET tracer for studying glutathione transferase. Bioorg Med Chem Lett (2012) 0.80
Gefitinib-related interstitial lung disease in Taiwanese patients with non-small-cell lung cancer. Clin Lung Cancer (2012) 0.79
Biological characterization of cetuximab-conjugated gold nanoparticles in a tumor animal model. Nanotechnology (2014) 0.79
Immunomodulation of curcumin on adoptive therapy with T cell functional imaging in mice. Cancer Prev Res (Phila) (2011) 0.79
Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model. Nucl Med Biol (2005) 0.79
Comparison of the efficacy and toxicity of two dose levels of cisplatin/5-fluorouracil as the chemoradiotherapy regimen for the treatment of locally advanced squamous cell carcinoma of the head and neck. Acta Otolaryngol (2011) 0.79
Development of thermosensitive poly(n-isopropylacrylamide-co-((2-dimethylamino) ethyl methacrylate))-based nanoparticles for controlled drug release. Nanotechnology (2011) 0.79
Noninvasive tumor imaging with high-frequency ultrasound and microPET in small animals. Ultrason Imaging (2007) 0.79
A design for automatic preparation of highly concentrated 188Re-perrhenate solutions. Appl Radiat Isot (2006) 0.78
A comparative study of primary and recurrent human glioblastoma multiforme using the small animal imaging and molecular expressive profiles. Mol Imaging Biol (2013) 0.78